vs
FVCBankcorp, Inc.（FVCB）与TriSalus Life Sciences, Inc.（TLSI）财务数据对比。点击上方公司名可切换其他公司
FVCBankcorp, Inc.的季度营收约是TriSalus Life Sciences, Inc.的1.3倍（$16.9M vs $13.2M），FVCBankcorp, Inc.同比增速更快（4377.5% vs 59.8%），FVCBankcorp, Inc.自由现金流更多（$23.8M vs $-2.5M），过去两年FVCBankcorp, Inc.的营收复合增速更高（586.6% vs 43.0%）
FVCBankcorp是总部位于美国弗吉尼亚州的银行控股公司，旗下运营社区银行FVCbank，面向大西洋中部地区的中小企业、专业人士及个人客户提供存款、贷款、按揭、财富管理等各类个人及商业银行金融服务。
TriSalus生命科学公司是一家临床阶段生物技术企业，专注于免疫肿瘤学与介入肿瘤学领域，研发专有的靶向给药技术，用于提升肝脏、胰腺等难治性实体瘤患者的治疗效果，主要在北美市场开展临床合作及业务运营。
FVCB vs TLSI — 直观对比
营收规模更大
FVCB
是对方的1.3倍
$13.2M
营收增速更快
FVCB
高出4317.7%
59.8%
自由现金流更多
FVCB
多$26.3M
$-2.5M
两年增速更快
FVCB
近两年复合增速
43.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $16.9M | $13.2M |
| 净利润 | — | $-9.8M |
| 毛利率 | — | 86.7% |
| 营业利润率 | 43.7% | -24.8% |
| 净利率 | — | -73.9% |
| 营收同比 | 4377.5% | 59.8% |
| 净利润同比 | — | 3.5% |
| 每股收益（稀释后） | $0.31 | $-0.22 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FVCBTLSI
| Q4 25 | $16.9M | $13.2M | ||
| Q3 25 | $416.0K | $11.6M | ||
| Q2 25 | $15.8M | $11.2M | ||
| Q1 25 | $382.0K | $9.2M | ||
| Q4 24 | $378.0K | $8.3M | ||
| Q3 24 | $412.0K | $7.3M | ||
| Q2 24 | $415.0K | $7.4M | ||
| Q1 24 | $359.0K | $6.5M |
净利润FVCBTLSI
| Q4 25 | — | $-9.8M | ||
| Q3 25 | $5.6M | $-10.8M | ||
| Q2 25 | $5.7M | $-8.3M | ||
| Q1 25 | $5.2M | $-10.4M | ||
| Q4 24 | — | $-10.1M | ||
| Q3 24 | $4.7M | $-2.4M | ||
| Q2 24 | $4.2M | $-4.3M | ||
| Q1 24 | $1.3M | $-13.2M |
毛利率FVCBTLSI
| Q4 25 | — | 86.7% | ||
| Q3 25 | — | 83.5% | ||
| Q2 25 | — | 83.9% | ||
| Q1 25 | — | 83.7% | ||
| Q4 24 | — | 85.3% | ||
| Q3 24 | — | 86.3% | ||
| Q2 24 | — | 87.6% | ||
| Q1 24 | — | 85.0% |
营业利润率FVCBTLSI
| Q4 25 | 43.7% | -24.8% | ||
| Q3 25 | — | -77.9% | ||
| Q2 25 | 45.9% | -65.4% | ||
| Q1 25 | — | -79.9% | ||
| Q4 24 | — | -91.8% | ||
| Q3 24 | — | -118.9% | ||
| Q2 24 | — | -111.0% | ||
| Q1 24 | — | -180.8% |
净利率FVCBTLSI
| Q4 25 | — | -73.9% | ||
| Q3 25 | 1341.1% | -93.5% | ||
| Q2 25 | 36.0% | -73.9% | ||
| Q1 25 | 1352.1% | -113.2% | ||
| Q4 24 | — | -122.4% | ||
| Q3 24 | 1133.3% | -32.6% | ||
| Q2 24 | 1001.2% | -58.8% | ||
| Q1 24 | 373.3% | -204.5% |
每股收益（稀释后）FVCBTLSI
| Q4 25 | $0.31 | $-0.22 | ||
| Q3 25 | $0.31 | $-0.96 | ||
| Q2 25 | $0.31 | $-0.27 | ||
| Q1 25 | $0.28 | $-0.39 | ||
| Q4 24 | $0.27 | $-0.38 | ||
| Q3 24 | $0.25 | $-0.12 | ||
| Q2 24 | $0.23 | $-0.21 | ||
| Q1 24 | $0.07 | $-0.60 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $20.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $253.6M | $-33.9M |
| 总资产 | $2.3B | $35.3M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资FVCBTLSI
| Q4 25 | — | $20.4M | ||
| Q3 25 | — | $22.7M | ||
| Q2 25 | — | $26.5M | ||
| Q1 25 | — | $13.0M | ||
| Q4 24 | — | $8.5M | ||
| Q3 24 | — | $11.3M | ||
| Q2 24 | — | $16.5M | ||
| Q1 24 | — | $4.0M |
股东权益FVCBTLSI
| Q4 25 | $253.6M | $-33.9M | ||
| Q3 25 | $249.8M | $-26.7M | ||
| Q2 25 | $243.2M | $-19.4M | ||
| Q1 25 | $242.3M | $-34.4M | ||
| Q4 24 | $235.4M | $-25.9M | ||
| Q3 24 | $230.8M | $-20.4M | ||
| Q2 24 | $226.5M | $-25.3M | ||
| Q1 24 | $220.7M | $-36.0M |
总资产FVCBTLSI
| Q4 25 | $2.3B | $35.3M | ||
| Q3 25 | $2.3B | $36.5M | ||
| Q2 25 | $2.2B | $41.3M | ||
| Q1 25 | $2.2B | $28.6M | ||
| Q4 24 | $2.2B | $24.0M | ||
| Q3 24 | $2.3B | $27.5M | ||
| Q2 24 | $2.3B | $32.4M | ||
| Q1 24 | $2.2B | $17.9M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $23.9M | $-2.5M |
| 自由现金流经营现金流 - 资本支出 | $23.8M | $-2.5M |
| 自由现金流率自由现金流/营收 | 140.7% | -19.1% |
| 资本支出强度资本支出/营收 | 0.3% | 0.3% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $40.0M | $-19.1M |
8季度趋势，按日历期对齐
经营现金流FVCBTLSI
| Q4 25 | $23.9M | $-2.5M | ||
| Q3 25 | $7.6M | $-3.7M | ||
| Q2 25 | $3.3M | $-7.3M | ||
| Q1 25 | $5.4M | $-4.5M | ||
| Q4 24 | $18.2M | $-5.7M | ||
| Q3 24 | $4.7M | $-10.8M | ||
| Q2 24 | $1.6M | $-13.4M | ||
| Q1 24 | $7.2M | $-10.9M |
自由现金流FVCBTLSI
| Q4 25 | $23.8M | $-2.5M | ||
| Q3 25 | $7.6M | $-3.9M | ||
| Q2 25 | $3.3M | $-7.4M | ||
| Q1 25 | $5.4M | $-5.3M | ||
| Q4 24 | $18.1M | $-5.8M | ||
| Q3 24 | $4.6M | $-11.0M | ||
| Q2 24 | $1.5M | $-13.5M | ||
| Q1 24 | $7.1M | $-10.9M |
自由现金流率FVCBTLSI
| Q4 25 | 140.7% | -19.1% | ||
| Q3 25 | 1818.0% | -33.9% | ||
| Q2 25 | 20.8% | -66.1% | ||
| Q1 25 | 1413.6% | -57.3% | ||
| Q4 24 | 4786.0% | -69.7% | ||
| Q3 24 | 1121.8% | -149.9% | ||
| Q2 24 | 361.2% | -183.1% | ||
| Q1 24 | 1988.3% | -169.3% |
资本支出强度FVCBTLSI
| Q4 25 | 0.3% | 0.3% | ||
| Q3 25 | 0.2% | 1.9% | ||
| Q2 25 | 0.1% | 0.8% | ||
| Q1 25 | 4.2% | 8.2% | ||
| Q4 24 | 37.3% | 0.6% | ||
| Q3 24 | 14.1% | 2.3% | ||
| Q2 24 | 12.8% | 0.8% | ||
| Q1 24 | 3.9% | 1.0% |
现金转化率FVCBTLSI
| Q4 25 | — | — | ||
| Q3 25 | 1.36× | — | ||
| Q2 25 | 0.58× | — | ||
| Q1 25 | 1.05× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.00× | — | ||
| Q2 24 | 0.37× | — | ||
| Q1 24 | 5.34× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
